Survival Analysis of Patients Undergoing Dialysis

JAMA: The Journal of the American Medical Association

Volumn 257, Issue 5, 1987, Pages 645-650

  Held, Philip J ^a   Pauly, Mark V ^b   Diamond, Louis ^c  

^a URBAN INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; DIALYSIS; EPIDEMIOLOGY; HUMAN; KIDNEY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HEMODIALYSIS, HOME; HUMAN; INCOME; KIDNEY, ARTIFICIAL; MALE; MIDDLE AGE; PERITONEAL DIALYSIS; PERSONNEL STAFFING AND SCHEDULING; RACIAL STOCKS; RENAL DIALYSIS; UNITED STATES;

EID: 0023153632     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03390050071021     Document Type: Article

References (38)

1. End-Stage Renal Disease Program Highlights. Health Care Financing Administration, US Dept of Health and Human Services, 1984.
2. Plough A, Salem S, Swartz M, et al: Case mix differences in end-stage renal disease. N Engl J Med 1985;310:1432-1436.
3. Cox D: Regression models and life tables. J R Stat Soc 1972;34:187-201.
4. Medicare Statistical Files Manual. Health Care Financing Administration, US Dept of Health and Human Services, 1983.
5. Held P, Pauly M: Patient Severity Measures and Their Impact on Medicare Costs in the ESRD Program. Washington, DC, Urban Institute, 1985.
6. Census of Population and Housing. US Dept of Commerce, Bureau of the Census, 1980.
7. 1977 Census of Retail Trade. US Dept of Commerce, Bureau of the Census, 1978.
8. City and County Data Book. US Dept of Commerce, Bureau of the Census, 1975.
9. Census of Population, General Social and Economic Characteristics. US Dept of Commerce, Bureau of the Census, 1969.
10. Diamond L, Held P, Palumbo MJ: Developing a Workable Case Mix Index That Relates to Cost: Experience for Patients With Chronic Renal Failure. Washington, DC, Urban Institute, 1984.
11. Anderson S, Auquier A, Hauck D, et al: Statistical Methods for Comparative Studies. New York, John Wiley & Sons Inc, 1980.
12. Harrell F: The PHGLM procedure, in Reinhardt PS (ed): SAS Supplemental Library User’s Guide. Cary, NC, SAS Institute Inc, 1980, pp 119-132.
13. Kmenta J: Elements of Econometrics. New York, Macmillan Publishing Co Inc, 1983.
14. Cheigh JS, Stenzel KH, Rubin AL, et al: Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 1983;75:602-606.
15. Barnes BA, Bergan JJ, Braun WE, et al: Renal transplantation in congenital and metabolic diseases. JAMA 1975;232:148-153.
16. Amend W, Vincenti F, Covey C, et al: Renal transplantation in systemic lupus erythematosus. Proc Clin Dial Transplant Forum 1977;7:18-21.
17. Coplon NS, Diskin CJ, Petersen J, et al: The long-term clinical course of systemic lupus erythematosus in ESRD. NEngl J Med 1983;308:186-190.
18. Hellerstedt WL, Johnson WS, Ascher N, et al: Survival rates for 2728 patients with ESRD. Mayo Clin Proc 1984;59:776-783.
19. Riley G, Lubitz J: Outcomes of surgery among the Medicare aged: Surgical volume and mortality. Health Care Financing Rev 1985;7:37-47.
20. Neu S, Kjellstrand CM: Stopping long-term dialysis. N Engl J Med 1986;314:14-20.
21. Bok DV, Pascual L, Herberger C, et al: Effect of multiple use of dialyzers on intradialytic symptoms. Proc Clin Dial Transplant Forum 1980;10: 92-99.
22. Wineman RJ: New technologies in automated reprocessing of hemodialyzers. Assoc Advance Med Instr Tech Anal Rev, 1985, pp 50-55.
23. Kant K, Pollack V, Cathey M, et al: Multiple use of dialyzers: Safety and efficacy. Kidney Int 1984;19:728-738.
24. Pollak VE, Kant SK, Parnell SL, et al: Repeated use of dialyzer is safe: Long-term observations on morbidity and mortality in patients with end-stage renal disease. Nephron 1986;42:217-223.
25. Wing AJ, Brunner HOA, Chantler C: Mortality and morbidity of reusing dialyzers. Br Med J 1978; 2:853-855.
26. Dumler F, Levin NW: Leukopenia and hypoximia. Arch Intern Med 1979;139:1103-1106.
27. Saudie E, Bruce L, Vincent PC: Modified neutropenic response to re-used dialyzers in patients with chronic renal failure. Clin Nephrol 1977;8:422-428.
28. Nakamura Y, Ozawa K, Akiba T, et al: Modified leukopenic response and complement activation during dialyzer reuse. Proc Clin Dial Transplant Forum 1980;10:237-239.
29. Favero MS, Deane N, Leger RT, et al: Effective multiple use of dialyzers on hepatitis B incidence in patients and staff. JAMA 1981;245:166-167.
30. Mathew TH, Fazzalari RA, Disney APS, et al: Multiple use of dialyzers: An Australian view. Nephron 1981;27:222-225.
31. Senate Special Committee on Aging: Dialyzer reuse. Contemp Dial Nephrol 1986;7:48-57.
32. Bolang, Reingold AL, Carson LA, et al: Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 1985;152:1013-1019.
33. Gibson JE: Formaldehyde Toxicity. Washington, DC, Hampshire Publishers, 1984.
34. Beal JR: Formaldehyde in dialysis patients, a review, in Formaldehyde: Analytical Chemistry and Toxicology. Washington, DC, American Chemical Society, 1985, pp 275-287.
35. Crosson JJ, Moulds J, Compty CM, et al: A clinical study of anti-NDP in the sera of patients in a large repetitive hemodialysis program. Kidney Int 1976;10:163-170.
36. National Cancer Institute: Cancer Facts. Bethesda, Md, Office of Cancer Communication, March 1986.
37. Held P, Pauly M: Competition of efficiency in the end stage renal disease program. J Health Economics 1983;2:95-118.
38. Bovbjerg R, Diamond L, Held P, et al: Continuous ambulatory peritoneal dialysis: Preliminary evidence in the debate over efficacy and cost. Health Affairs 1983;2:96-102.